中医药治疗宫颈鳞癌术后及放化疗后SCC升高1例

陈绅铭; 肖静

意见反馈

您当前的位置：

首页 >

文章列表页 >

中医药治疗宫颈鳞癌术后及放化疗后SCC升高1例

中国中医药临床案例成果库 | 病例报告

上一篇: 何晓瑾辨治强直性脊柱炎生物制剂干预失败医案1则

下一篇: 关幼波教授“气血辨证”学术思想治疗失代偿期乙肝肝硬化病案一则

中医药治疗宫颈鳞癌术后及放化疗后SCC升高1例
A Case Report of SCC Increased After Treatment of Cervical Squamous Cell Cancer
1.广州中医药大学第二临床医学院，广州 510006
2.广州中医药大学第二附属医院妇科，广州 510006
DOI：

扫描看全文

陈绅铭, 肖静. 中医药治疗宫颈鳞癌术后及放化疗后SCC升高1例[DB/OL].（2023-10-27）[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails?columnId=43052713&Fpath=home&index=0

CHEN Shenming, XIAO Jing. A Case Report of SCC Increased After Treatment of Cervical Squamous Cell Cancer[DB/OL].（2023-10-27）[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails?columnId=43052713&Fpath=home&index=0
陈绅铭, 肖静. 中医药治疗宫颈鳞癌术后及放化疗后SCC升高1例[DB/OL].（2023-10-27）[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails?columnId=43052713&Fpath=home&index=0 DOI：

CHEN Shenming, XIAO Jing. A Case Report of SCC Increased After Treatment of Cervical Squamous Cell Cancer[DB/OL].（2023-10-27）[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails?columnId=43052713&Fpath=home&index=0 DOI：

摘要

病史摘要,2,一名56岁的女性被诊断为宫颈鳞状细胞癌，FIGO IIIC1p期。完成规范治疗后定期随访，1年后复查肿瘤标志物SCC高于正常水平，随后的随访中SCC呈持续上升趋势，至随访第2年SCC上升到正常上限的2倍。使用切脉针灸+中药疗法治疗4周后，SCC即降至正常水平。至今患者仍在门诊进行中药巩固治疗，复查均未见复发征象。本案例体现了切脉针灸+中药治疗在肿瘤领域的疗效，值得进一步研究。中医诊断　子宫颈癌（肝郁脾虚，痰瘀互结）西医诊断　宫颈鳞状细胞癌 IIIC1p期干预措施　切脉针灸+中药综合治疗。疗效转归　无病生存期大于4年，SCC升高后无病生存期接近2年。

Abstract

Summary of case history,　A 56 year old female was diagnosed with cervical squamous cell carcinoma, FIGO stage IIIC1p. Regular follow-up was conducted after the completion of standardized treatment. One year later, the tumor marker SCC was rechecked to be higher than the normal level. In the subsequent follow-up, SCC continued to rise, and by the second year of follow-up, SCC had risen to twice the upper limit of normal. After 4 weeks of treatment with pulse acupuncture and traditional Chinese medicine, SCC decreased to the normal level. So far, the patient is still in the outpatient department for consolidation treatment with Chinese medicine, and no recurrence sign is found in the reexamination. This case reflects the efficacy of pulse acupuncture combine with Chinese medicine treatment in the field of cancer, which is worth studying and promoting.,TCM diagnosis,　cervical cancer (stagnation of liver qi and spleen deficiency, phlegm and blood stasis),Western medicine diagnosis,　cervical squamous cell carcinoma stage (FIGO stage IIIC1p),Therapeutic methods,　pulse acupuncture and traditional Chinese herbal medicine,Clinical outcomes,　disease-free survival,>,4 y.

关键词

宫颈癌SCC中药切脉针灸

Keywords

cervical cancerSCCtraditional Chinese medicinepuls acupuncture

references

Zhu H. Squamous Cell Carcinoma Antigen: Clinical Application and Research Status. Diagnostics (Basel).2022;12(5):1065.

Gadducci A, Tana R, Cosio S, Genazzani AR. The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: a review of the literature.Crit Rev Oncol Hematol.2008;66(1):10-20.

Hu YY, Fan W, Zhang X, et al. Complementary Roles of Squamous Cell Carcinoma Antigen and (18)F-FDG PET/CT in Suspected Recurrence of Cervical Squamous Cell Cancer [J] Cancer. 2015;6(3):287-291.

Pan L, Cheng J, Zhou M, et al. The SUVmax (maximum standardized uptake value for F-18 fluorodeoxyglucose) and serum squamous cell carcinoma antigen (SCC-ag) function as prognostic biomarkers in patients with primary cervical cancer [J] Cancer Res Clin Oncol. 2012;138(2):239-246.

杨志寅.诊断学大辞典:[M].北京:华夏出版社,2004.

Cohen PA, Jhingran A, Oaknin A, Denny L. Cervical cancer. Lancet [J] 2019;393(10167):169-182.

Yang D, Wang J, Zhang L. Serum SCCA levels in patients suffering cancers or other diseases [J] Prog Mol Biol Transl Sci. 2019;162:165-175.

俞云.切脉针灸治癌[M].合肥:安徽科学技术出版社,1994.

俞云.切脉针灸－黄帝内经针法[M]. 北京:人民卫生出版社,2013.

陈小凤,肖静,俞云.俞云切脉针灸对生化复发型卵巢癌的针药结合治疗心得[J].时珍国医国药,2019,30(2):474-476

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

卵巢癌生化复发验案1例

阮诗玮“角药”在肾系疾病中的运用

中药治疗胶质瘤个案报道

中药联合推拿治疗儿童孤独症谱系障碍1例